EMBRAC-B.STEMBRAC-B.STSTO
Loading
EBITDA Over TimeExpanding
Percentile Rank100
3Y CAGR+45.5%
5Y CAGR+45.9%
Studio
Year-over-Year Change

Earnings before interest, taxes, depreciation, and amortization

3Y CAGR
+45.5%/yr
vs +96.5%/yr prior
5Y CAGR
+45.9%/yr
Consistent
Acceleration
-51.0pp
Decelerating
Percentile
P100
Near historical high
vs 5Y Ago
6.6x
Strong expansion
Streak
1 yr
Consecutive growthExpanding
PeriodValueYoY Change
2025$12.54B+166.8%
2024$4.70B-61.6%
2023$12.24B+201.0%
2022$4.07B-4.6%
2021$4.26B+124.6%
2020$1.90B+20.0%
2019$1.58B+480.4%
2018$272.63M+106.0%
2017$132.37M+26.6%
2016$104.59M-